2025年5月25日 周日
Home > Archive>Volume 31, Issue 5, 2023 >456-460. DOI:10.20039/j.cnki.1007 3949.2023.05.013
PDF HTML XML Export Cite reminder
Research progress in the relationship between Akkermansia and atherosclerosis
Author:
Affiliation:

1.Department of Cardiology, the 2nd Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150001, China;2.The Key Laboratory of Myocardial Ischemia, Chinese Ministry of Education, Harbin, Heilongjiang 150001, China;3.Department of Cardiology, the 1st Affiliated Hospital of University of South China, Hengyang, Hunan 421001, China)

Clc Number:

R5

  • Article
    • | |
  • Metrics
    • |
  • Reference [42]
    • |
  • Related [20]
    • | | |
  • Comments
    Abstract:

    Atherosclerosis (As), a complex chronic inflammatory disease, that is a major cause of cardiovascular diseases (CVD) including ischemic heart disease and stroke, causing high morbidity and mortality worldwide. In recent years, the role of gut microbiota in atherosclerosis has received extensive attention. However, as an important anti-atherosclerosis beneficial bacteria, Akkermansia is rarely reviewed. In-depth study of the pathogenesis and potential treatment of atherosclerosis is the focus of current medical development. Therefore, this article reviews how Akkermansia exerts its anti-atherosclerotic effect and its relationship with anti-atherosclerotic drugs.

    Reference
    [1] LIBBY P, BURING J E, BADIMON L, et al.Atherosclerosis.Nat Rev Dis Primers, 9,5(1):56.
    [2] BRANDSMA E, KLOOSTERHUIS N J, KOSTER M, et al.A proinflammatory gut microbiota increases systemic inflammation and accelerates atherosclerosis.Circ Res, 9,4(1):94-100.
    [3] DOMINGUEZ-BELLO M G, GODOY-VITORINO F, KNIGHT R, et al.Role of the microbiome in human development.Gut, 9,8(6):1108-1114.
    [4] QIN J, LI R, RAES J, et al.A human gut microbial gene catalogue established by metagenomic sequencing.Nature, 0,4(7285):59-65.
    [5] MILANI C, DURANTI S, BOTTACINI F, et al.The first microbial colonizers of the human gut:composition, activities, and health implications of the infant gut microbiota.Microbiol Mol Biol Rev, 7,1(4):e00036-17.
    [6] DERRIEN M, VAUGHAN E E, PLUGGE C M, et al.Akkermansia muciniphila gen.nov., sp.nov., a human intestinal mucin-degrading bacterium.Int J Syst Evol Microbiol, 4,4(Pt 5):1469-1476.
    [7] DERRIEN M, COLLADO M C, BEN-AMOR K, et al.The mucin degrader akkermansia muciniphila is an abundant resident of the human intestinal tract.Appl Environ Microbiol, 8,4(5):1646-1648.
    [8] JAYACHANDRAN M, CHUNG S S M, XU B J.A critical review of the relationship between dietary components, the gut microbe Akkermansia muciniphila, and human health.Crit Rev Food Sci Nutr, 0,0(13):2265-2276.
    [9] NAITO Y, UCHIYAMA K, TAKAGI T.A next-generation beneficial microbe:Akkermansia muciniphila.J Clin Biochem Nutr, 8,3(1):33-35.
    [10] KALIA VC, GONG C, SHANMUGAM R, et al.The emerging biotherapeutic agent:Akkermansia.Indian J Microbiol, 2,2(1):1-10.
    [11] RODRIGUES V F, ELIAS-OLIVEIRA J, PEREIRA I S, et al.Akkermansia muciniphila and gut immune system:a good friendship that attenuates inflammatory bowel disease, obesity, and diabetes.Front Immunol, 2,3:934695.
    [12] LEWIS C V, WR T.Intestinal barrier dysfunction as a therapeutic target for cardiovascular disease.Am J Physiol Heart Circ Physiol, 0,9(6):1227-1233.
    [13] BANSIL R, TURNER B S.The biology of mucus:composition, synthesis and organization.Adv Drug Deliv Rev, 8,4:3-15.
    [14] REUNANEN J, KAINULAINEN V, HUUSKONEN L, et al.Akkermansia muciniphila adheres to enterocytes and strengthens the integrity of the epithelial cell layer.Appl Environ Microbiol, 5,1(11):3655-3662.
    [15] COLLADO M C, DERRIEN M, ISOLAURI E, et al.Intestinal integrity and Akkermansia muciniphila, a mucin-degrading member of the intestinal microbiota present in infants, adults, and the elderly.Appl Environ Microbiol, 7,3(23):7767-7770.
    [16] PLOVIER H, EVERARD A, DRUART C, et al.A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice.Nat Med, 7,3(1):107-113.
    [17] LI J, LIN S, VANHOUTTE P M, et al.Akkermansia muciniphila protects against atherosclerosis by preventing metabolic endotoxemia-induced inflammation in ApoE－/－ Mice.Circulation, 6,3(24):2434-2446.
    [18] ZHU Y, LI T H, DIN A U, et al.Beneficial effects of enterococcus faecalis in hypercholesterolemic mice on cholesterol transportation and gut microbiota.Appl Microbiol Biotechnol, 9,3(7):3181-3191.
    [19] KATIRAEI S, DE VRIES M R, COSTAIN A H, et al.Akkermansia muciniphila exerts lipid-lowering and immunomodulatory effects without affecting neointima formation in hyperlipidemic ApoE*3-leiden.CETP mice.Mol Nutr Food Res, 0,4(15):e1900732.
    [20] BAVINENI M, WASSENAAR T M, AGNIHOTRI K, et al.Mechanisms linking preterm birth to onset of cardiovascular disease later in adulthood.Eur Heart J, 9,0(14):1107-1112.
    [21] BAE M, CASSILLY C D, LIU A A, et al.Akkermansia muciniphila phospholipid induces homeostatic immune responses.Nature, 2,8(7921):168-173.
    [22] LU Y C, YEH W C, OHASHI P S.LPS/TLR4 signal transduction pathway.Cytokine, 8,2(2):145-151.
    [23] 赵鹏, 刘新新, 田进伟.肠道菌群代谢物与心血管疾病关系的研究进展.中国动脉硬化杂志, 1,9(12):1094-1098.ZHAO P, LIU X X, TIAN J W.Research progress in the relationship between intestinal flora metabolites and cardio-vascular disease.Chin J Arterioscler, 1,9(12):1094-1098.
    [24] KASAHARA K, REY F E.The emerging role of gut microbial metabolism on cardiovascular disease.Curr Opin Microbiol, 9,0:64-70.
    [25] GREGORY J C, BUFFA J A, ORG E, et al.Transmission of atherosclerosis susceptibility with gut microbial transplantation.J Biol Chem, 5,0(9):5647-5660.
    [26] CHEN M L, ZHU X H, RAN L, et al.Trimethylamine-N-oxide induces vascular inflammation by activating the NLRP3 inflammasome through the SIRT3-SOD2-mtROS signaling pathway.J Am Heart Assoc, 7,6(9):e006347.
    [27] CHEN M L, YI L, ZHANG Y, et al.Resveratrol attenuates trimethylamine-N-oxide (TMAO)-induced atherosclerosis by regulating TMAO synthesis and bile acid metabolism via remodeling of the gut microbiota.mBio, 6,7(2):e02210-e02215.
    [28] WANG Z N, HAZEN J, JIA X, et al.The nutritional supplement L-alpha glycerylphosphorylcholine promotes atherosclerosis.Int J Mol Sci, 1,2(24):13477.
    [29] SONG D Y, HAO J Y, FAN D M.Biological properties and clinical applications of berberine.Front Med, 0,4(5):564-582.
    [30] DONG C R, YU J Q, YANG Y N, et al.Berberine, a potential prebiotic to indirectly promote Akkermansia growth through stimulating gut mucin secretion.Biomed Pharmacother, 1,9:111595.
    [31] ZHU L, ZHANG D Y, ZHU H, et al.Berberine treatment increases Akkermansia in the gut and improves high-fat diet-induced atherosclerosis in ApoE－/－ mice.Atherosclerosis, 8,8:117-126.
    [32] CHENG T T, LI C K, SHEN L Y, et al.The intestinal effect of atorvastatin:Akkermansia muciniphila and barrier function.Front Microbiol, 1,2:797062.
    [33] WANG L J, ZHOU W W, GUO M Y, et al.The gut microbiota is associated with clinical response to statin treatment in patients with coronary artery disease.Atherosclerosis, 1,5:16-23.
    [34] KHAN T J, AHMED Y M, ZAMZAMI M A, et al.Atorvastatin treatment modulates the gut microbiota of the hypercholesterolemic patients.OMICS, 8,2(2):154-163.
    [35] SU C, LI X, YANG Y, et al.Metformin alleviates choline diet-induced TMAO elevation in C57BL/6J mice by influencing gut-microbiota composition and functionality.Nutr Diabetes, 1,1(1):27.
    [36] TAN J, MCKENZIE C, POTAMITIS M, et al.The role of short-chain fatty acids in health and disease.Adv Immunol, 4,1:91-119.
    [37] DE LA CUESTA-ZULUAGA J, MUELLER N T, CORRALES-AGUDELO V, et al.Metformin is associated with higher relative abundance of mucin-degrading Akkermansia muciniphila and several short-chain fatty acid-producing microbiota in the gut.Diabetes Care, 7,0(1):54-62.
    [38] YAN N, WANG L J, LI Y W, et al.Metformin intervention ameliorates As in ApoE－/－ mice through restoring gut dysbiosis and anti-inflammation.PLoS One, 1,6(7):e0254321.
    [39] LIN K Y, WANG X D, LI J, et al.Anti-atherosclerotic effects of geraniin through the gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway in mice.Phytomedicine, 2,1:154104.
    [40] CHEN P Y, LI S M, KOH Y C, et al.Oolong tea extract and citrus peel polymethoxyflavones reduce transformation of L-carnitine to trimethylamine-N-Oxide and decrease vascular inflammation in L-carnitine feeding mice.J Agric Food Chem, 9,7(28):7869-7879.
    [41] WANG X, LI X, DONG Y.Vitamin D decreases plasma trimethylamine-N-oxide level in mice by regulating gut microbiota.Biomed Res Int, 0,0:9896743.
    [42] SHI N, ZHANG S Y, SILVERMAN G, et al.Protective effect of hydroxychloroquine on rheumatoid arthritis-associated atherosclerosis.Animal Model Exp Med, 9,2(2):98-106.
    Cited by
Get Citation

ZHAO Peng, ZHENG Yuqi, TIAN Jinwei, LIU Xinxin. Research progress in the relationship between Akkermansia and atherosclerosis[J]. Editorial Office of Chinese Journal of Arteriosclerosis,2023,31(5):456-460.

Copy
Share
Article Metrics
  • Abstract:279
  • PDF: 835
  • HTML: 0
  • Cited by: 0
History
  • Received:August 31,2022
  • Revised:October 29,2022
  • Online: May 19,2023
Article QR Code

You are the 48936 visitor

Post Code：421001 Fax：0734-8160523

Phone：0734-8160765 E-mail：dmzzbjb@163.net

Editorial Office of Chinese Journal of Arteriosclerosis ® 2025